Literature DB >> 22876164

Expression of lysophosphatidic acid receptors and local invasiveness and metastasis in Chinese pancreatic cancers.

Y L Gong1, C J Tao, M Hu, J F Chen, X F Cao, G M Lv, P Li.   

Abstract

BACKGROUND AND OBJECTIVES: The present study evaluated the potential role of lysophosphatidic acid receptors (lpars) in processes leading to local invasiveness and metastasis in Chinese pancreatic carcinoma.
METHODS: Real-time reverse-transcriptase polymerase chain reaction and Western blot analysis were used to detect expression of lpars in tumour and adjacent non-tumour tissues from patients with surgically resected pancreatic carcinoma. Surgical specimens from 50 patients were examined for relative expression of each receptor's messenger rna (mrna) and protein. Findings were analyzed for correlations with tumour size, pathologic classification, clinical stage, and infiltration of capsule and lymphonodi.
RESULTS: Increased levels of mrna of lpars (lpar1lpar3 < lpar2) were found in the pancreatic cancer tissues examined. Low levels of transcripts for lpar1, lpar2, and lpar3 receptors were detectable in adjacent non-tumour tissues. The difference in lpar1 protein expression between tumour and adjacent non-tumour tissues does not seem significant, but the signals of lpar2 expression in pancreatic cancer tumour tissues were significantly amplified compared with those in adjacent non-tumour tissues. Tumour and adjacent non-tumour tissues both weakly expressed lpar3 protein with no statistical difference. However, expression of lpar1, lpar2, and lpar3 showed an obvious correlation with infiltration of capsule cells, surrounding lymphonodi, and specific histopathologic features.
CONCLUSIONS: Lysophosphatidic acid receptor is a promising indicator for pancreatic cancer, and our findings suggested that lpar2 might be a potential target for clinical treatment of pancreatic cancer.

Entities:  

Keywords:  Lysophosphatidic acid; lpars; pancreatic cancer

Year:  2012        PMID: 22876164      PMCID: PMC3413255          DOI: 10.3747/co.19.1138

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  24 in total

1.  Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer.

Authors:  K M Schulte; A Beyer; K Köhrer; S Oberhäuser; H D Röher
Journal:  Int J Cancer       Date:  2001-04-15       Impact factor: 7.396

2.  The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.

Authors:  Ahmed Boucharaba; Claire-Marie Serre; Julien Guglielmi; Jean-Claude Bordet; Philippe Clézardin; Olivier Peyruchaud
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

3.  Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.

Authors:  K Bandoh; J Aoki; H Hosono; S Kobayashi; T Kobayashi; K Murakami-Murofushi; M Tsujimoto; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

4.  Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

Authors:  Takayuki Yamada; Koichi Sato; Mayumi Komachi; Enkhzol Malchinkhuu; Masayuki Tobo; Takao Kimura; Atsushi Kuwabara; Yasuhiro Yanagita; Toshiro Ikeya; Yoshifumi Tanahashi; Tetsushi Ogawa; Susumu Ohwada; Yasuo Morishita; Hideo Ohta; Doon-Soon Im; Koichi Tamoto; Hideaki Tomura; Fumikazu Okajima
Journal:  J Biol Chem       Date:  2003-12-03       Impact factor: 5.157

Review 5.  Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate.

Authors:  E J Goetzl; S An
Journal:  FASEB J       Date:  1998-12       Impact factor: 5.191

6.  Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.

Authors:  Dai Shida; Toshiaki Watanabe; Junken Aoki; Kotaro Hama; Joji Kitayama; Hirofumi Sonoda; Yasuhiro Kishi; Hironori Yamaguchi; Shin Sasaki; Akihiro Sako; Tsuyoshi Konishi; Hiroyuki Arai; Hirokazu Nagawa
Journal:  Lab Invest       Date:  2004-10       Impact factor: 5.662

7.  Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2).

Authors:  Mei-Chuan Huang; Hsin-Yu Lee; Che-Chung Yeh; Yvonne Kong; Charles J Zaloudek; Edward J Goetzl
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

Review 8.  Lysophosphatidic acid is a bioactive mediator in ovarian cancer.

Authors:  Xianjun Fang; Michel Schummer; Muling Mao; Shuangxing Yu; Fazal Haq Tabassam; Ramona Swaby; Yutaka Hasegawa; Janos L Tanyi; Ruthie LaPushin; Astrid Eder; Robert Jaffe; Jim Erickson; Gordon B Mills
Journal:  Biochim Biophys Acta       Date:  2002-05-23

9.  In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice.

Authors:  Amy H Yang; Isao Ishii; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2002-05-23

10.  Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma.

Authors:  Joji Kitayama; Dai Shida; Akihiro Sako; Makoto Ishikawa; Kotaro Hama; Junken Aoki; Hiroyuki Arai; Hirokazu Nagawa
Journal:  Breast Cancer Res       Date:  2004-09-22       Impact factor: 6.466

View more
  2 in total

Review 1.  Lipid Phosphate Phosphatases and Cancer.

Authors:  Xiaoyun Tang; David N Brindley
Journal:  Biomolecules       Date:  2020-09-02

2.  The transcriptome-wide association search for genes and genetic variants which associate with BMI and gestational weight gain in women with type 1 diabetes.

Authors:  Agnieszka H Ludwig-Słomczyńska; Michał T Seweryn; Przemysław Kapusta; Ewelina Pitera; Urszula Mantaj; Katarzyna Cyganek; Paweł Gutaj; Łucja Dobrucka; Ewa Wender-Ożegowska; Maciej T Małecki; Paweł P Wołkow
Journal:  Mol Med       Date:  2021-01-20       Impact factor: 6.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.